AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.


  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

Lam Research Earnings, Revenue Beat in Q2 By


© Reuters. Lam Research Earnings, Revenue Beat in Q2 – Lam Research (NASDAQ:) reported on Wednesday second quarter that beat analysts’ forecasts and revenue that topped expectations. Lam Research announced earnings per share of $4.01 on revenue of $2.58B. Analysts polled by anticipated EPS of $3.84 on revenueRead More →